Global Chronic Pain Treatment Market
Pharmaceuticals

Future Demand and Leading Companies Shaping the Chronic Pain Treatment Market to 2029

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Chronic Pain Treatment Sector?

In the past few years, the chronic pain treatment market has experienced significant growth. The market value is projected to increase from $99.64 billion in 2024 to $109.05 billion in 2025, signifying a compound annual growth rate (CAGR) of 9.4%. Factors contributing to the growth in this period include an aging population, increased occurrence of chronic diseases, a heightened understanding of pain management, the widespread use of prescription opioids, and the broadening of health insurance coverage.

The market size for chronic pain treatment is anticipated to experience robust expansion in the coming years, with an estimated growth to reach $155 billion by 2029, showcasing a compound annual growth rate (CAGR) of 9.2%. The predicted growth during the forecasted period can be associated with an inclination towards non-opioid alternatives, heightened government investment in pain research, mounting demand for personalized medicine, increased uptake of digital tools for pain management, and the evolving implementation of Artificial Intelligence in diagnosing and planning pain treatment. Significant trends during the forecast period comprise progress in neuromodulation therapies, incorporation of telemedicine into pain care, the advent of cannabinoid-based therapies, emphasis on multidisciplinary treatment strategies, and the surge in wearable devices for pain monitoring.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

What Forces Are Driving The Growth Of The Chronic Pain Treatment Market?

The increasing instances of arthritis pain are set to drive the growth of the chronic pain treatment market in the future. This discomfort in the joints due to inflammation or degeneration from arthritis is what is referred to as arthritis pain. The increase in arthritis pain is mainly attributed to an aging population because the likelihood of experiencing joint wear and tear elevates naturally with age, leading to a higher occurrence of arthritis-related conditions. To alleviate arthritis pain, chronic pain treatment focuses on inflammation and nerve sensitivity, which lessens discomfort, improves joint function, and boosts the overall quality of life for those struggling with constant arthritis symptoms. For example, the Office for Health Improvement and Disparities, a UK-based government department, reported that in March 2023, in the previous year, 17.6% of people aged 16 and over revealed that they had a long-term musculoskeletal (MSK) ailment, such as arthritis or enduring back or joint problems, exhibiting an increase from 17.0% in 2021. Consequently, the increasing instances of arthritis pain are fueling the expansion of the chronic pain treatment market.

How Is The Chronic Pain Treatment Industry Segmented Across Key Parameters?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

What Notable Trends Are Shaping The Direction Of The Chronic Pain Treatment Market?

In the chronic pain treatment market, prominent businesses are prioritizing the innovation of sophisticated products like rechargeable spinal cord stimulators to heighten patient comfort and optimize lasting pain management results. A rechargeable spinal cord stimulator, which is a medical device placed close to the spine to emit electric pulses that obstruct pain signs, can be replenished externally without requiring surgery. It serves to control chronic pain by breaking off pain routes in the spinal cord and lowers pain perception in individuals with conditions like failed back surgery syndrome or neuropathic pain. For instance, Abbott Laboratories, a medical device firm from the US, introduced the Eterna spinal cord stimulation system in December 2022. The Eterna unit, smaller than an Apple AirPods case, is extremely neat and unobtrusive, providing a user-friendly solution for treating chronic pain. It offers significant pain relief, shown potential for decreasing dependence on opioid medications and is created for long-term, minimally intrusive use, ultimately improving daily operations and patients’ overall life quality.

Which Companies Currently Dominate The Competitive Landscape In The Chronic Pain Treatment Industry?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

Which Geographic Regions Are Driving Demand In The Chronic Pain Treatment Market?

North America was the largest region in the chronic pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24504&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model